Ann Arbor, MI, United States of America

Dennis Joseph Mc Namara

This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis Joseph Mc Namara. Retrieved from https://idiyas.com/inventor/dennis-joseph-mc-namara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Certainly! Here is the article about inventor Dennis Joseph Mc Namara:

Title: Innovator Spotlight: Dennis Joseph Mc Namara

Introduction: Meet Dennis Joseph Mc Namara, a talented inventor based in Ann Arbor, MI (US) known for his groundbreaking work in developing Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors for treating cell proliferative disorders.

Latest Patents: Dennis Joseph Mc Namara holds 1 patent for his innovative compounds designed to combat cancer and restenosis by inhibiting cdks and growth factor-mediated kinases.

Career Highlights: Dennis Joseph Mc Namara is affiliated with Warner-Lambert Company, a prestigious pharmaceutical company known for its cutting-edge research and development in the healthcare industry.

Collaborations: Throughout his career, Dennis Joseph Mc Namara has collaborated with esteemed coworkers such as Richard John Booth and Ellen Myra Dobrusin, contributing to a dynamic and innovative work environment.

Conclusion: Dennis Joseph Mc Namara's dedication to advancing medical treatments through his inventive compounds showcases his profound impact in the field of healthcare innovation. His collaboration with like-minded colleagues underscores the importance of teamwork in driving meaningful progress in the fight against cell proliferative disorders.

If you need more information or assistance, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…